UA110889C2 - N-метил-4-бензилкарбамідопіридинію хлорид і спосіб його отримання - Google Patents

N-метил-4-бензилкарбамідопіридинію хлорид і спосіб його отримання

Info

Publication number
UA110889C2
UA110889C2 UAA201412193A UAA201412193A UA110889C2 UA 110889 C2 UA110889 C2 UA 110889C2 UA A201412193 A UAA201412193 A UA A201412193A UA A201412193 A UAA201412193 A UA A201412193A UA 110889 C2 UA110889 C2 UA 110889C2
Authority
UA
Ukraine
Prior art keywords
methyl
receipt
urea
pyridinium chloride
benzyl pyridinium
Prior art date
Application number
UAA201412193A
Other languages
English (en)
Inventor
Філя Жебровська
Григорій Костюк
Михайло Ванат
Віктор Маргітич
Original Assignee
Фармак Інтернешнл Холдінг Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармак Інтернешнл Холдінг Гмбх filed Critical Фармак Інтернешнл Холдінг Гмбх
Publication of UA110889C2 publication Critical patent/UA110889C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Дана заявка стосується нової солі N-метил-4-бензилкарбамідопіридинію, способу її отримання, фармацевтичної композиції, що включає цю сполуку, та її застосування для лікування або профілактики вірусних захворювань.
UAA201412193A 2012-05-18 2012-05-18 N-метил-4-бензилкарбамідопіридинію хлорид і спосіб його отримання UA110889C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/059258 WO2013170901A1 (en) 2012-05-18 2012-05-18 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation

Publications (1)

Publication Number Publication Date
UA110889C2 true UA110889C2 (uk) 2016-02-25

Family

ID=48483057

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201412193A UA110889C2 (uk) 2012-05-18 2012-05-18 N-метил-4-бензилкарбамідопіридинію хлорид і спосіб його отримання

Country Status (12)

Country Link
US (2) US9493416B2 (uk)
EP (1) EP2850063B1 (uk)
JP (1) JP2015517513A (uk)
KR (1) KR101777561B1 (uk)
BR (1) BR112014028576B1 (uk)
CA (1) CA2873977C (uk)
EA (1) EA025409B1 (uk)
ES (1) ES2573286T3 (uk)
IN (1) IN2014DN10683A (uk)
PL (1) PL2850063T3 (uk)
UA (1) UA110889C2 (uk)
WO (2) WO2013170901A1 (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2689775C1 (ru) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Способ промышленного производства N-метил-4-бензилкарбамидопиридиния йодида

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU58612A1 (ru) 1939-10-29 1939-11-30 П.С. Мордовин Устройство дл включени в одну станционную линию двухабонентских аппаратов
SU548612A1 (ru) 1975-07-18 1977-02-28 Казанский Химико-Технологический Институт Им.С.М.Кирова Способ получени 10-хлорфеноксарсина
US4115390A (en) * 1977-08-19 1978-09-19 Nardi John C Method for the preparation of 1-alkyl pyridinium chlorides
ATE178320T1 (de) * 1992-06-04 1999-04-15 Micro Flo Co Mepiquat chloride
WO2011158058A1 (en) 2010-06-17 2011-12-22 Farmak International Holding Gmbh α-CRYSTALLINE FORM OF CARBABENZPYRIDE

Also Published As

Publication number Publication date
US9493416B2 (en) 2016-11-15
CA2873977A1 (en) 2013-11-21
US20140357677A1 (en) 2014-12-04
EA201492161A1 (ru) 2015-03-31
BR112014028576A2 (pt) 2017-06-27
JP2015517513A (ja) 2015-06-22
PL2850063T3 (pl) 2016-10-31
WO2013171307A1 (en) 2013-11-21
IN2014DN10683A (uk) 2015-08-28
CN104321312A (zh) 2015-01-28
ES2573286T3 (es) 2016-06-07
US20170037011A1 (en) 2017-02-09
WO2013170901A1 (en) 2013-11-21
EP2850063B1 (en) 2016-04-13
KR101777561B1 (ko) 2017-09-12
EA025409B1 (ru) 2016-12-30
EP2850063A1 (en) 2015-03-25
KR20150013124A (ko) 2015-02-04
BR112014028576B1 (pt) 2020-11-03
CA2873977C (en) 2019-09-17

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
SMT201700034B (it) Composti di urea biciclica, tiourea, guanidina e cianoguanidina utili per il trattamento del dolore
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015002524A2 (pt) derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças.
BR112015003376A8 (pt) composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
BR112014003681A2 (pt) composto, composição farmacêutica, produto de combinação farmacêutica, uso de um composto, e, método para tratar doenças ou condições
MD4589C1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
ZA201308617B (en) Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
HK1220324A1 (zh) 用於治療血管緊張素相關疾病的方法、化合物和組合物
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
PH12016501462A1 (en) Neprilysin inhibitors
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
IN2015DN03998A (uk)
EA201300946A1 (ru) Асимметричные мочевины и их медицинское применение
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
PH12014502743A1 (en) Carbamate/urea derivatives
PH12018501709A1 (en) Naphthridinedione derivatives
DK3241551T3 (da) Farmaceutisk sammensætning til behandling af kræft, indeholdende lactatmetalsalt
PH12014501712A1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
PH12014502065A1 (en) Vesicular formulations
BR112015005627A2 (pt) composto, composição farmacêutica, uso de composto, método de tratamento e invenção.
DK3725810T3 (da) Kombinationterapi, der involverer antistoffer mod claudin 18.2 til behandling af cancer